Systems and methods for treatment of hearing using dihexa
US-2024424050-A1 · Dec 26, 2024 · US
Anti-inflammatory properties of marine lipid compositions
US10117882B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10117882-B2 |
| Application number | US-84995010-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 4, 2010 |
| Priority date | May 5, 2006 |
| Publication date | Nov 6, 2018 |
| Grant date | Nov 6, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.
First claim
Opening claim text (preview).
The invention claimed is: 1. A gel capsule containing a lipid composition comprising a mixture of phospholipid molecules, having the following general structure: wherein said mixture of phospholipid molecules is characterized in comprising at least 1% docosahexaenoic acid (DHA) residues or eicosopentaenoic acid (EPA) residues at positions R1 or R2 and from 15 to 45% of OH at positions R1 or R2 and wherein R1 and R2 are not simultaneously —OH, wherein R3 is a moiety selected from the group consisting of choline, ethanolamine, inositol and serine moieties, and wherein said mixture of phospholipids is acylated in a range from 55% to about 85%. 2. The composition as claimed in claim 1 , wherein said mixture of phospholipids has a ratio of EPA/DHA ranging from 1:1 to 4:1. 3. The composition of claim 1 , wherein said mixture of phospholipids having a ratio of EPA/DHA ranging from 2:1 to 4:1. 4. The composition of claim 1 , wherein said composition further comprises a lipid carrier in a ratio of from 1:10 to 10:1 to said phospholipids. 5. The composition of claim 4 , wherein said lipid carrier is selected from the group consisting of a triglyceride, a diglyceride, fatty acid ethyl ester, and a fatty acid methyl ester and combinations thereof. 6. The composition of claim 4 , wherein said lipid carrier and said mixture of phospholipids are in a ratio of from about 5:1 to 1:5. 7. The composition of claim 4 , wherein said composition comprises from about 20% to about 90% of said mixture of phospholipids and from about 10% to about 50% of said lipid carrier.
Assignees
Inventors
Classifications
Nutrients, e.g. vitamins, minerals · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Phosphatides, e.g. lecithin · CPC title
- A61K31/685Primary
one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10117882B2 cover?
- Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cytokines.
- Who is the assignee on this patent?
- Bruheim Inge, Griinari Mikko, Banni Sebastiano, and 3 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/685. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).